<DOC>
	<DOCNO>NCT02785874</DOCNO>
	<brief_summary>Statin preventive medicine hepatitis B hepatitis C decrease risk turn liver cancer , however , investigator also discover patient take Statin live longer patient n't take Statin incidence liver cancer death case .</brief_summary>
	<brief_title>Statin With Palliative Therapy HCC</brief_title>
	<detailed_description>Most liver cancer patient accept cure main objective treatment diagnosis choose alternative therapy palliative base , hepatic arterial chemoembolization , chemotherapy radiation therapy . Statin preventive medicine hepatitis B hepatitis C decrease risk turn liver cancer , yet clinical effect Statin still unknown . In previous study 20,220 liver cancer patient health care database , investigator discover patient take Statin live longer patient n't take Statin incidence liver cancer death case . This study continuation previous health insurance database study clinical trial verify whether Statin could prolong disease-free survival role palliative treatment liver cancer .</detailed_description>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<mesh_term>Hydroxymethylglutaryl-CoA Reductase Inhibitors</mesh_term>
	<criteria>1 . &gt; 20 year old . 2 . BCLC stage B , stage C stage D 1 . Cancer diagnosis HCC conÔ¨Årmed incurable . 2 . &lt; 20 year old , &gt; 90years old . 3 . Patients judge ineligible study entry investigator subinvestigator</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>